Visibuilt
Stub active Updated Jul 21, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Visibuilt is a Danish biotech developing visiBINDER, a mycelium-based biobased binder designed to replace carbon-intensive materials such as bitumen and cement in paving and infrastructure applications 12. The company was founded in 2022 and closed a €3.34 million Seed round on 2026-07-13 to move its technology from lab pilots toward market validation and industry testing 12.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-07-13 | Seed | €3.34M | EIFO, Unconventional Ventures | Proptechfonden, EMDFonden 12 |
What Investors Say
No independently sourced investor quotes found at time of publication.
What Founders Say
“Closing this seed round is an important milestone for Visibuilt. It enables us to mature our technical platform, validate our solution at a larger scale, and take the next steps towards the market.”
— Line Kloster Pedersen, Founder & CEO, Visibuilt 1
Sources
-
“Visibuilt Raises EUR 3.34 Million to Bring Biobased Binders Closer to Market,” PropTech Connect, July 13, 2026. Accessed July 21, 2026. https://proptechconnect.com/visibuilt-raises-eur-334-million-to-bring-biobased-binders-closer-to-market↩↩↩↩
-
“Mycelium-based paving material developer Visibuilt raises €3.34 million out of Denmark,” EU-Startups, July 13, 2026. Accessed July 21, 2026. https://www.eu-startups.com/2026/07/mycelium-based-paving-material-developer-visibuilt-raises-e3-34-million-out-denmark/↩↩↩